Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Booking Holdings Inc (BKNG) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Booking Holdings IncTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Booking Holdings Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Booking Holdings Inc trades at $212.21 (market cap $159.95B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $83.19B). The key difference: Booking Holdings Inc is the larger of the two by market cap, and Booking Holdings Inc pays the higher dividend (0.79%). Which is the better fit depends on your goals.

BKNGREGN
Market Cap
$159.95B$83.19B
Sector
Consumer CyclicalHealth
52-Week High
$228.83$812.27
52-Week Low
$154.13$555.51
Enterprise Value
$163.43B$77.90B
Dividend Yield
0.79%0.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Booking Holdings Inc

BKNG trades at $214.42, up 3.39% on strong Q2 2026 earnings beats, with bullish technical signals and a consensus price target of $239.31. Revenue growth accelerated to $26.92B in 2025, though net income dipped to $5.40B. The stock shows robust profitability with a 25.53% net margin and high ROE, but faces geopolitical and competitive pressures.

Outlook remains positive with resilient travel demand and AI integration driving efficiency, but risks include Middle East volatility and high debt levels. Analysts are overwhelmingly bullish with 64% buy ratings, supporting upside potential amid near-term headwinds.

Regeneron Pharmaceuticals Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Booking Holdings Inc

Booking is the world's largest online travel agency by revenue, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates a number of branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.

Read more on BKNG

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN